Singapore markets closed

Rosetta Genomics Ltd. (ROSGQ)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
0.00010.0000 (0.00%)
At close: 11:48AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 29.65k
Enterprise value 29.65k
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.00
Price/book (mrq)0.01
Enterprise value/revenue 0.00
Enterprise value/EBITDA -0.00

Trading information

Stock price history

Beta (5Y monthly) 19.25
52-week change 30.00%
S&P500 52-week change 323.76%
52-week high 30.0001
52-week low 30.0001
50-day moving average 30.0001
200-day moving average 30.0001

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 55.93M
Implied shares outstanding 6296.49M
Float 82.18M
% held by insiders 10.00%
% held by institutions 10.00%
Shares short (30 Apr 2018) 4299.25k
Short ratio (30 Apr 2018) 44.1
Short % of float (30 Apr 2018) 45.05%
Short % of shares outstanding (30 Apr 2018) 45.05%
Shares short (prior month 29 Mar 2018) 4364.66k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 317 Mar 2017
Ex-dividend date 4N/A
Last split factor 21:12
Last split date 317 Mar 2017

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2016
Most-recent quarter (mrq)30 Jun 2017

Profitability

Profit margin 0.00%
Operating margin (ttm)-157.59%

Management effectiveness

Return on assets (ttm)-60.19%
Return on equity (ttm)-137.95%

Income statement

Revenue (ttm)2.86M
Revenue per share (ttm)1.37
Quarterly revenue growth (yoy)115.30%
Gross profit (ttm)N/A
EBITDA -10.35M
Net income avi to common (ttm)-9.48M
Diluted EPS (ttm)-0.2700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.32M
Total cash per share (mrq)0.51
Total debt (mrq)2.45M
Total debt/equity (mrq)222.84%
Current ratio (mrq)2.09
Book value per share (mrq)0.43

Cash flow statement

Operating cash flow (ttm)-11.68M
Levered free cash flow (ttm)-6.04M